Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
QMRO Home
Wolfson Institute of Preventive Medicine
Centre for Cancer Prevention
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
QMRO Home
Wolfson Institute of Preventive Medicine
Centre for Cancer Prevention
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
View/
Open
Wallden Development and verification of the PAM50-based Prosigna breast cancer gene signature assay 2015 Published.pdf (1.773Mb)
Volume
8
DOI
10.1186/s12920-015-0129-6
Journal
BMC MEDICAL GENOMICS
ISSN
1755-8794
Metadata
Show full item record
Authors
Wallden, B; Storhoff, J; Nielsen, T; Dowidar, N; Schaper, C; Ferree, S; Liu, S; Leung, S; Geiss, G; Snider, J
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12235
Collections
Centre for Cancer Prevention
[860]
Licence information
CC-BY
Copyright statements
© 2015 Wallden et al